Skip to main navigation Skip to search Skip to main content
Brad Kahl

View Scopus Profile

Brad Kahl

Professor of Medicine, Director of Lymphoma

 https://orcid.org/0000-0003-0459-6609
    • 25105
      Citations
    1997 …2026

    Research activity per year

    Personal profile

    Research interests

    Developing new and better treatment approaches to lymphoma and chronic lymphocytic leukemia.

    Clinical interests

    Lymphoma, CLL

    Fingerprint

    Dive into the research topics where Brad Kahl is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
    • 6 Similar Profiles
    View full fingerprint

    Collaborations and top research areas from the last five years

    Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
    Explore network further

    • An Evaluation of Ibrutinib and Ixazomib in Patients With Relapsed/Refractory Mantle Cell Lymphoma: PrE0404

      Cohen, J. B., Portell, C. A., Hamadani, M., Jegede, O., Diefenbach, C., Fletcher, C., Matasar, M., Landsburg, D., Mantha, S. & Kahl, B., Jul 2026, In: Clinical Lymphoma, Myeloma and Leukemia. 26, 7, p. 465-473.e1

      Research output: Contribution to journal › Article › peer-review

      1   Link opens in a new tab Scopus citations

    • A randomized phase 2 study of ipilimumab, nivolumab, and brentuximab vedotin in patients with relapsed Hodgkin lymphoma

      Diefenbach, C. S., Jegede, O., Wang, V., Ansell, S. M., Kostakoglu, L., Steidl, C., Natkunam, Y., Scott, D. W., Ambinder, R. F., David, K. A., Advani, R. H., Bartlett, N. L., Roberston, M. A., Thomas, S. P., Cohen, J., Ibrahimi, S., Goyal, G., Mehta-Shah, N., Amengual, J. E. & Forlenza, C. J. & 4 others, Cole, P. D., Duan, F., Kelly, K. & Kahl, B. S., Apr 30 2026, In: Blood. 147, 18, p. 2041-2052 12 p.

      Research output: Contribution to journal › Article › peer-review

      Open Access
      3   Link opens in a new tab Scopus citations

    • Benefit of rituximab maintenance after first-line bendamustine-rituximab in patients with mantle cell lymphoma

      Wang, Y., Larson, M. C., Hwang, S. R., Villa, D., Kugathasan, L., Kumar, A., Joseph, A., Brooks, T. R., Hill, B. T., Bond, D. A., Maddocks, K. J., Nizamuddin, I. A., Kahl, B. S., Danilov, A., Argao, C., Ruan, J., Ryan, C. E., Merryman, R. W., Grover, N. S. & Khan, N. B. & 36 others, Ouchveridze, E., Tun, A. M., Ayyappan, S., Mou, E., Pongas, G. N., Lossos, I. S., Harris, Z. I., Munoz, J. L., Young, P., Portell, C. A., Baidoun, F., Alhaj Moustafa, M., Reagan, P. M., Banaszak, L. G., Pophali, P. A., Velayati, A., Greenwell, I. B., Gerber, D., Jain, P., Wang, M. L., Narkhede, M. S., Mehta, A., Stack, A. C., Messmer, M. R., Bhansali, R. S., Barta, S. K., Moyo, T. K., Ghosh, N., Kamdar, M. K., Anna, J., Stanisic, A. V., Karmali, R., Maurer, M. J., Cerhan, J. R., Cohen, J. B. & Martin, P., Feb 24 2026, In: Blood Advances. 10, 4, p. 1372-1380 9 p.

      Research output: Contribution to journal › Article › peer-review

      Open Access
      4   Link opens in a new tab Scopus citations

    • Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 2.2026 Featured Updates to the NCCN Guidelines

      Wierda, W. G., Brown, J., Abramson, J. S., Awan, F., Bociek, G., Boyer, D., Cortese, M., Cripe, L., D’angelo, C., Darnell, E., Davis, R. S., Eradat, H., Esteghamat, N., Fitzgerald, L., Fletcher, C. D., Gaballa, S., Huntington, S., Kahl, B., Kamdar, M. & Kipps, T. J. & 17 others, Ma, S., Mosse, C. A., Nakhoda, S., Parikh, S. A., Riedell, P., Schorr, A., Schuster, S., Seshadri, M., Shanafelt, T., Siddiqi, T., Sitlinger, A., Thompson, M., Ujjani, C., Wagner-Johnston, N., Woyach, J. A., Dwyer, M. & Sundar, H., Mar 1 2026, In: JNCCN Journal of the National Comprehensive Cancer Network. 24, 3, p. 68-80 13 p.

      Research output: Contribution to journal › Article › peer-review

      2   Link opens in a new tab Scopus citations

    • Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

      Merryman, R., Rutherford, S. C., Ansell, S., Armand, P., Leonard, J. P., Nastoupil, L., Smith, S. M., Timmerman, J., Zelenetz, A. D., Gutierrez, M., Béguelin, W., Casulo, C., Cerhan, J., Green, M., Kahl, B., Kridel, R., Link, B., Maurer, M. J., Nadel, B. & Radtke, A. J. & 5 others, Luttwak, E., Salles, G., Sehn, L., Pasqualucci, L. & LaCasce, A. S., Mar 10 2026, In: Blood Advances. 10, 5, p. 1591-1602 12 p.

      Research output: Contribution to journal › Comment/debate

      Open Access
      1   Link opens in a new tab Scopus citations
    View all 336 Research outputs